
Call for more taxes on smoking to make up cuts to global aid funding
In the past decade the number of countries with at least one tobacco control measure in place – whether that's increased taxes, health warnings on packages, bans on advertising or smoking in public places – jumped from roughly 45 to more than 150. But of the seven such tobacco control measures recommended by the WHO, making cigarettes and other tobacco products more expensive through taxes has seen least progress.
The WHO put the overall slowing of progress down to disruptions during the Covid-19 pandemic as well as challenges posed by the need to regulate a raft of new products like vapes, which the report said 'threaten[ed] to undo earlier progress made' in the more than 20 years since the WHO Framework Convention on Tobacco Control was agreed .
'Raising prices through taxation is the most effective way to reduce tobacco use,' the WHO report said, adding that this measure had only risen from 13 per cent in 2018 to 15 per cent in 2024.
Speaking at the World Conference on Tobacco Control in Dublin, WHO director general Dr Tedros Adhanom Ghebreyesus said: "The greatest gains have been made in developing countries where despite aggressive industry interference, governments and civil society have demonstrated that change for the better is possible. Yet, challenges remain.'
'Raising taxes on tobacco is a proven way to reduce tobacco use while generating revenues to reinvest in health."
Dr Tedros added that raising taxes on cigarettes could help make up for cuts to global aid funding – particularly driven by Donald Trump and the US, but also including the UK and a number of other countries – which is expected to hit tobacco control efforts.
'And with [overseas development assistance] falling or the funding level for health falling, the taxes could be used for the gaps that are happening in many countries,' he said as he also called for more research on the health impact of new tobacco and nicotine products like vapes and smokeless tobacco.
Andrew Black, who works on the WHO Framework Convention on Tobacco Control said: 'We're facing a really challenging problem especially when it comes to securing the resources that are needed to fight tobacco'.
'What we really need to do is to encourage governments to look domestically for sources of revenue... The very obvious place to look is through tobacco taxation,' he added.
A tool developed by Johns Hopkins University in the US found increasing taxes on a pack of cigarettes in Kenya by 75 per cent could raise enough money to cover more than three-quarters of the funds lost to the country through foreign aid cuts.
Dr Guy Marks, president of the International Union Against Tuberculosis and Lung Disease, said: 'The reduction in funding for global health is a huge catastrophe for many things. Actually, tobacco control is one area which should be less affected by this than most others [if governments raise tobacco taxes].'
'Why does that not happen? It does not happen, because governments are convinced that they actually gain more revenue for continuing to allow tobacco to be sold," he added. "Why is this the case? Because there are huge political and other interests in countries that support the sale of tobacco.'
Global tobacco industry watchdog STOP estimated $1.8 trillion (£1.3tn) US dollars were lost worldwide to tobacco due to the costs of healthcare and lost wages from tobacco-related illness.
But some major strides have been made towards controlling tobacco use around the world over the past ten years. More countries have applied graphic health warnings to cigarette packs since 2007 than any other measure, with bans on smoking in public places being the next most common new measure to be introduced.
But in many cases countries applying stark health warnings to cigarette packs demand no such thing on smokeless tobacco, which the WHO said could, 'wrongly suggest that some products are harmless'. And while there has been a rise in rules or bans on e-cigarettes, also known as vapes, more than 60 countries have no restrictions on sales of vapes at all.
Hazel Cheeseman, the chief executive of UK public health charity Action on Smoking and Health (ASH), said the progress was 'heartening' but that there was much left to be done.
'Tobacco taxes are one of the most effective ways to reduce smoking and can also raise revenue to support health systems. With 134 countries yet to make progress in this area this is an area of significantly untapped potential,' she said.
'Ending the harms from tobacco takes time and I hope the UK government will continue to provide assistance to other countries for the long term helping to secure a planet where no one dies from tobacco related illness.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BreakingNews.ie
13 minutes ago
- BreakingNews.ie
Sinn Féin says Government ‘facilitating' failures at CHI amid data probe
The Government 'facilitates' failures at Children's Health Ireland (CHI), Sinn Féin has said, as the State data watchdog launched a probe into its handling of child health records. The Data Protection Commission (DPC) opened an inquiry on Thursday into the physical safety and security of children's health records within one specific CHI facility in Tallaght. Advertisement The DPC said it became aware there were potential issues at this site from a number of sources of information, including through protected disclosures and a breach notification from CHI itself. Having reviewed the information, the DPC conducted an unannounced site inspection on July 16th and has now decided to launch a formal inquiry. The probe will examine CHI's compliance with their GDPR obligations, in particular relating to the security of personal data and the processes that it has in place for managing physical records at CHI Tallaght. Asked about the matter, Sinn Féin health spokesman David Cullinane said there had been a series of clinical, governance and management failures at CHI. Advertisement He said these included the implantation of unauthorised non-medical grade springs, unnecessary hip surgeries, and problems around insourcing. Mr Cullinane said he has 'absolutely no confidence in CHI', adding that the trust between CHI and parents had been 'shattered'. He said: 'But it's the Government that facilitates and allows an organisation of Children's Health Ireland to continue with all of those failures. 'And what's really frustrating for advocate groups and campaign groups and families is that all of these failures that we're now hearing about, they were raising, they were talking about. Advertisement 'They were telling the stories, and they were ignored, and they were met with the wall of resistance.'


Reuters
13 minutes ago
- Reuters
Novo Nordisk debuts Wegovy in South Africa as weight-loss drugs race gathers pace
JOHANNESBURG, Aug 14 (Reuters) - Danish drugmaker Novo Nordisk ( opens new tab introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's (LLY.N), opens new tab Mounjaro which launched in the country eight months ago. South Africa has the continent's fourth-highest number of adults with diabetes, according to the International Diabetes Federation, making it a key growth opportunity. "One in two adults right now in South Africa is living with excess weight or obesity," Sara Norcross, general manager of Novo Nordisk South Africa, said at the launch event. "Wegovy is the first and only once-weekly GLP-1 right now that is registered for weight management," she added, referring to a class of therapies known as GLP-1 receptor agonists that make people feel fuller for longer. Novo already sells Ozempic in South Africa for diabetes treatment. Eli Lilly also sells Mounjaro only for the treatment of Type 2 diabetes in South Africa, through Aspen Pharmacare (APNJ.J), opens new tab, though some people take the drug for weight loss. Wegovy, already launched in 35 countries, will be available in five dose strengths in South Africa, and its pricing will be disclosed next week, the company said. Mounjaro, also a once-weekly injectable treatment, is priced from 3,400 rand ($194) for four vials of its lowest dose, depending on the pharmacy or clinic. Novo plans to expand Wegovy into other African markets, Norcross told Reuters, as part of a push to boost sales outside the United States. "I believe it's going to be launching in Egypt soon, and registrations are being submitted for other countries too," she said. The company generates the bulk of its profits from Wegovy sales in the U.S., where it competes with Eli Lilly's Zepbound and Mounjaro. More than a billion people have obesity worldwide, according to the World Health Organization, and around 70% of them live in low and middle-income countries, highlighting the potential impact of weight-loss drugs like Wegovy in underserved markets. In South Africa alone, around 20 million people are overweight or obese, though less than 1% currently receive treatment, Norcross said. The WHO plans to back the use of weight-loss drugs to treat obesity in adults for the first time, Reuters reported in May, signalling a significant shift in the agency's stance on tackling the global health challenge. ($1 = 17.5258 rand)


BreakingNews.ie
43 minutes ago
- BreakingNews.ie
Electric Picnic attendees advised to look after their 'festival health'
As Electric Picnic approaches, attendees are being advised to look after their "festival health". The HSE harm reduction initiative will be in Stradbally for the duration of the festival, which runs from Friday, August 29th - Sunday, August 31st. Advertisement The back-of-house testing can be carried out on drugs connected with a person brought to a medical tent and on drugs placed in "surrender bins". Chief executive and founder of Psych Care, Mick Ledden, said there are some issues first timers may have. "People who are underprepared maybe practically and then the weather gets them, maybe their mental health becomes an issue when they're at the festival, fights with friends, difficulties there, or all the common substance-induced issues," he said. "We can dive into specifics but I think really to inform yourself first and foremost about what these drugs are. "Don't take anything that somebody just offers you, you know, to just be really clear on what your boundaries are."